Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbosymag versus placebo in adults with functional dyspepsia
2006-005338-19Phase 3Completed
- Sponsor
- Laboratoires Grimberg
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of activated charcoal + magnesium oxide + simethicone in functional dyspepsia (FD) (2 arms), sponsored by Laboratoires Grimberg. Primary endpoints: Digestive symptom global score change and Postprandial stomach heaviness change. Started Feb 2007; status: completed.
02
Drugs
activated charcoal + magnesium oxide + simethicone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2006-005338-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005338-19.